Estradiol suppresses vascular monocyte chemotactic protein-1 expression during early atherogenesis

American Journal of Obstetrics and Gynecology

Volumn 187, Issue 6, 2002, Pages 1544-1549

  Seli, Emre ^a   Kayisli, Umit Ali ^a,b   Selam, Belgin ^a   Seli, Meltem ^a   Arici, Aydin ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Aorta; Atherosclerosis; Estrogen; Mice; Monocyte chemotactic protein 1; Vascular

Indexed keywords

ESTRADIOL; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTERY WALL; ARTICLE; ATHEROGENESIS; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; HOMOZYGOSITY; HORMONAL REGULATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID STORAGE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RECEPTOR BINDING; SMOOTH MUSCLE FIBER; STIMULUS RESPONSE; VASCULAR DISEASE;

EID: 0036910213     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.127306     Document Type: Article

References (25)

1. American Heart Association. Heart and Stroke Facts: Statistical Update. Dallas: American Heart Association; 1997.
2. Stary HC. Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children. Atherosclerosis 1987;64:91-108.
3. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH. Menopause and the risk of coronary heart disease in women. N Engl J Med 1987;316:1305-10.
4. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys: Lack of an effect of added progesterone. Arteriosclerosis 1990;10:1051-7.
5. Sullivan TR, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, et al. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 1995;96:2482-8.
6. Writing Group fox the PEPI Trial. Effect of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 1995;273:199-208.
7. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Ann Rev Biochem 1983;52:223-61.
8. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801-9.
9. Yla-Hertualla SY, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, Leonard EJ, et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991;88:5252-6.
10. Gu L, Yoshikatsu O, Clinton SK, Gerard C, Sukhova GK, Libby P, et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-81.
11. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998;394:894-7.
12. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, et al. Monocyte chemotactic protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1999;19:1518-25.
13. Arici A, Senturk LM, Seli E, Bahtiyar MO, Kim G. Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone. Biol Reprod 1999;61:85-90.
14. Seli E, Pehlivan T, Garcia-Velasco JA, Mulayim N, Arici A. Estrogen regulates MCP-1 in human coronary artery endothelial cells: A mechanism for its anti-atherogenic effect. Fertil Steril 2001;77:542-7.
15. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J. Hypercholesterolemia in low-density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993;92:883-93.
16. Somers KD, Koenig M, Schechter GL. Growth of head and neck squamous cell carcinoma in nude mice: Potentiation of laryngeal carcinoma by 17beta-estradiol. J Natl Cancer Inst 1988;80:688-91.
17. Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 1985;57:65-73.
18. Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 1995;36:2320-8.
19. Pervin S, Singh R, Rosenfeld ME, Navab M, Chaudhuri G, Nathan L. Estradiol suppresses MCP-1 expression in vivo: Implications for atherosclerosis. Arterioscler Thromb Vasc Biol 1998;18:1575-82.
20. Sack MN, Rader DJ, Cannon RO. Oestrogen and inhibition of oxidation of low-density lipoproteins in post-menopausal women. Lancet 1994;343:269-70.
21. Hayashi T, Jayachandran M, Sumi D, Thakur NK, Esaki T, Muto E, et al. Physiological concentration of 17 beta estradiol retards the progression of severe atherosclerosis induced by a high-cholesterol-diet and balloon catheter injury: Role of NO. Arterioscler Thromb Vasc Biol 2000;20:1613-21.
22. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemotactic protein-1 in cultured endothelial cells. Circ Res 1995;76:980-6.
23. Caulin-Glaser T, Garcia-Cardena G, Sarrel P, Sessa WC, Bender JR. 17 β-Estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca mobilization. Circ Res 1997;81:885-92.
24. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan TR, Lubahn DB, et al. Estrogen inhibits the vascular injury response in estrogen receptor a-deficient mice. Nature Med 1997;3:545-8.
25. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, et al. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice. Proc Natl Acad Sci U S A 1999;96:15133-6.